開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
Spain May harmonized CPI (HICP) preliminary MoM +0.1% vs expected +0.2%; April +0.70%.
2026-05-29
Spain May harmonized CPI (HICP) preliminary MoM +0.1% vs expected +0.2%; April +0.70%.
返回
其他消息
2026-05-29
Hungary's Prime Minister Magyar clarified that the total EU funds released to date amount to €16.4 billion.
Hungary's Prime Minister Magyar clarified that the total EU funds released to date amount to €16.4 billion.
2026-05-29
BeiGene said Antaishi (tarlatamab injection), the first and currently only DLL3×CD3 bispecific T‑cell engager co‑developed and to be commercialized with Amgen, received approval from China’s National Medical Products Administration (NMPA) for adults with extensive‑stage small‑cell lung cancer (ES‑SCLC) who progressed after one prior systemic therapy, including platinum‑based chemotherapy.
BeiGene said Antaishi (tarlatamab injection), the first and currently only DLL3×CD3 bispecific T‑cell engager co‑developed and to be commercialized with Amgen, received approval from China’s National Medical Products Administration (NMPA) for adults with extensive‑stage small‑cell lung cancer (ES‑SCLC) who progressed after one prior systemic therapy, including platinum‑based chemotherapy.
Chat with us
, powered by
LiveChat